Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer

Journal of Clinical Oncology

Volumn 21, Issue 12, 2003, Pages 2288-2293

  Chan, Annie On On ^a   Chu, Kent Man ^a   Lam, Shiu Kum ^a   Wong, Benjamin Chun Yu ^a   Kwok, Ka Fai ^a   Law, Simon ^a   Ko, Samuel ^a   Hui, Wai Mo ^a   Yueng, Yui Hung ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; UVOMORULIN; CADHERIN; TUMOR MARKER;

AGED; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; ADENOCARCINOMA; ADULT; BLOOD; CANCER STAGING; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; CADHERINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0038488107     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.08.078     Document Type: Article

References (31)

1. World Cancer Research Fund and American Institute for Cancer Research: Food, Nutrition, and the Prevention of Cancer: A Global Perspective. Washington, DC, World Cancer Research Fund and American Institute for Cancer Research, 1997, p 150
2. Behrens J, Mareel MM, Van Roy FM, et al: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108:2435-2447, 1989
3. Frixen UH, Behrens J, Sachs M, et al: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185, 1991
4. Vleminckx K, Vakaet L Jr, Mareel M, et al: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119, 1991
5. Takeichi M: Cadherins in cancer: Implications for invasion and metastasis. Curr Opin Cell Biol 5:806-811, 1993
6. Becker KF, Atkinson MJ, Reich U, et al: Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Mol Genet 2:803-804, 1993
7. Tamura G, Yin J, Wang S, et al: E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92:569-573, 2000
8. Machado JC, Oliveira C, Carvalho R, et al: E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20:1525-1528, 2001
9. Grady WM, Willis J, Guilford PJ, et al: Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26:16-17, 2000
10. Gofuku J, Shiozaki H, Doki Y, et al: Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. Br J Cancer 78:1095-1101, 1998
11. Chan AO, Lam SK, Chu KM, et al: Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut 48:808-811, 2001
12. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31-49, 1965
13. Katayama M, Hirai S, Kamihagi K, et al: Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 69:580-585, 1994
14. Kodera Y, Yamamura Y, Torii A, et al: The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer. Am J Gastroenterol 91:49-53, 1996
15. Jawhari A, Jordan S, Poole S, et al: Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival. Gastroenterology 112:46-54, 1997
16. Lo Gerfo P, Herter FP: Carcinoembryonic antigen and prognosis in patients with colon cancer. Ann Surg 181:81-84, 1975
17. Beatty JD, Romero C, Brown PW, et al: Clinical value of carcinoembryonic antigen: Diagnosis, prognosis, and follow-up of patients with cancer. Arch Surg 114:563-567, 1979
18. Herrera MA, Chu TM, Holyoke ED, et al: CEA monitoring of palliative treatment for colorectal carcinoma. Ann Surg 185:23-30, 1977
19. Wang WS, Lin JK, Chiou TJ, et al: Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol 30:12-16, 2000
20. Watine J, Friedberg B: Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer. Jpn J Clin Oncol 30:522-523, 2000
21. Nakane Y, Okamura S, Akehira K, et al: Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 73:2703-2708, 1994
22. Ikeda Y, Oomori H, Koyanagi N, et al: Prognostic value of combination assays for CEA and CA19-9 in gastric cancer. Oncology 52:483-486, 1996
23. Victorzon M, Haglund C, Lundin J, et al: A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer. Eur J Surg Oncol 21:379-384, 1995
24. Touitou Y, Haus E (eds): Biologic Rhythms in Clinical and Laboratory Medicine (ed 2). Heidelberg, Germnany, Springer, 1994
25. Watine J, Miédougé M: Pre-analytical variation of laboratory variables. Clin Chem Lab Med 38:263, 2000
26. Duraker N, Celik AN: The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: Comparison with CEA. J Surg Oncol 76:266-271, 2001
27. Ychou M, Duffour J, Kramar A, et al: Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers 16:105-110, 2000
28. Nakata B, Hirakawa YS, Chung K, et al: Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma. Cancer 83:2488-2492, 1998
29. Koshikawa N, Yasumitsu H, Umeda M, et al: Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res 52:5046-5053, 1992
30. Ozawa M, Engel J, Kemler R: Single amino acid substitutions in one Ca2+ binding site of uvomorulin abolish the adhesive function. Cell 63:1033-1038, 1990
31. Thompson JA, Grunert F, Zimmermann W: Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives. J Clin Lab Anal 5:344-366, 1991